All Stories

  1. Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4
  2. Clinical Guideline Inconsistency Regarding the Prevention of Hepatitis B and C Virus Transmission